Evidence map›Paper›PMID 34610983›Full record

ArticleDiabetes2021

The Tetracycline-Controlled Transactivator (Tet-On/Off) System in β-Cells Reduces Insulin Expression and Secretion in Mice.

Nathalie Jouvet, Khalil Bouyakdan, Scott A Campbell, Cindy Baldwin, Shannon E Townsend, Maureen A Gannon, Vincent Poitout, Thierry Alquier, Jennifer L Estall

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. DecodingbioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Nathalie JouvetInstitut de recherches cliniques de Montréal (IRCM), Montréal, Quebec, Canada nathalie.jouvet@ircm.qc.ca jennifer.estall@ircm.qc.ca.
Khalil BouyakdanMontreal Diabetes Research Centre, Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Scott A CampbellMontreal Diabetes Research Centre, Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Cindy BaldwinInstitut de recherches cliniques de Montréal (IRCM), Montréal, Quebec, Canada.
Shannon E TownsendDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN.
Maureen A GannonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN.ORCID 0000-0003-3287-8101
Vincent PoitoutMontreal Diabetes Research Centre, Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.ORCID 0000-0002-6555-5053
Thierry AlquierMontreal Diabetes Research Centre, Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada.
Jennifer L EstallInstitut de recherches cliniques de Montréal (IRCM), Montréal, Quebec, Canada nathalie.jouvet@ircm.qc.ca jennifer.estall@ircm.qc.ca.ORCID 0000-0002-9838-1440
Centre Hospitalier de l’Université de Montréal · CAMontreal Clinical Research Institute · CATennessee Valley Authority · USVanderbilt University · US

Funding

MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Neutral lipid dysregulation of the pancreatic beta-cellR01DK058096 · NIDDK · UNIVERSITY OF MONTREAL HOSPITAL · PI POITOUT, VINCENT · 2001 to 2020
$3.9M
Manipulating islet GPCR activity to promote beta cell proliferation and survivalR01DK120626 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GANNON, MAUREEN A · 2019 to 2022
$1.7M
BLRD VA I01 BX005399CIHR MOP 77686CIHR PJT-148771CIHR PJT-153035NIDDK NIH HHS R01 DK058096NIDDK NIH HHS R01 DK120626NIDDK NIH HHS T32 DK007563
6 · The paper itself

Abstract

Controllable genetic manipulation is an indispensable tool in research, greatly advancing our understanding of cell biology and physiology. However in β-cells, transgene silencing, low inducibility, ectopic expression, and off-targets effects are persistent challenges. In this study, we investigated whether an inducible Tetracycline (Tet)-Off system with β-cell-specific mouse insulin promoter (MIP)-itTA-driven expression of tetracycline operon (TetO)-Cre

Indexed as

AnimalsCells, CulturedFemaleGene Expression RegulationInsulinInsulin-Secreting CellsIntegrasesMaleMiceMice, Inbred C57BLMice, TransgenicPromoter Regions, GeneticTetracyclineTrans-ActivatorsTransgenesCre recombinaseInsulinIntegrasesTetracyclineTrans-Activators

Identifiers

PMID34610983
PMCPMC8660978
OpenAlexW3204107460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.